134 related articles for article (PubMed ID: 22939842)
1. Regulation of CYP3A4 and CYP3A5 expression and modulation of "intracrine" metabolism of androgens in prostate cells by liganded vitamin D receptor.
Maguire O; Pollock C; Martin P; Owen A; Smyth T; Doherty D; Campbell MJ; McClean S; Thompson P
Mol Cell Endocrinol; 2012 Nov; 364(1-2):54-64. PubMed ID: 22939842
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor agonist EB1089 is a potent regulator of prostatic "intracrine" metabolism.
Doherty D; Dvorkin SA; Rodriguez EP; Thompson PD
Prostate; 2014 Feb; 74(3):273-85. PubMed ID: 24242708
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing of the vitamin D receptor modulates target gene expression and promotes ligand-independent functions.
Annalora AJ; Jozic M; Marcus CB; Iversen PL
Toxicol Appl Pharmacol; 2019 Feb; 364():55-67. PubMed ID: 30552932
[TBL] [Abstract][Full Text] [Related]
4. Loss of CYP3A7 gene induction by 1,25-dihydroxyvitamin D3 is caused by less binding of VDR to the proximal ER6 in CYP3A7 gene.
Hara H; Yasunami Y; Adachi T
Biochem Biophys Res Commun; 2004 Sep; 321(4):909-15. PubMed ID: 15358113
[TBL] [Abstract][Full Text] [Related]
5. SIRT1 enzymatically potentiates 1,25-dihydroxyvitamin D
Sabir MS; Khan Z; Hu C; Galligan MA; Dussik CM; Mallick S; Stone AD; Batie SF; Jacobs ET; Whitfield GK; Haussler MR; Heck MC; Jurutka PW
J Steroid Biochem Mol Biol; 2017 Sep; 172():117-129. PubMed ID: 28636886
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxy vitamin D3.
Thummel KE; Brimer C; Yasuda K; Thottassery J; Senn T; Lin Y; Ishizuka H; Kharasch E; Schuetz J; Schuetz E
Mol Pharmacol; 2001 Dec; 60(6):1399-406. PubMed ID: 11723248
[TBL] [Abstract][Full Text] [Related]
7. Molecular and functional comparison of 1,25-dihydroxyvitamin D(3) and the novel vitamin D receptor ligand, lithocholic acid, in activating transcription of cytochrome P450 3A4.
Jurutka PW; Thompson PD; Whitfield GK; Eichhorst KR; Hall N; Dominguez CE; Hsieh JC; Haussler CA; Haussler MR
J Cell Biochem; 2005 Apr; 94(5):917-43. PubMed ID: 15578590
[TBL] [Abstract][Full Text] [Related]
8. Involvement of promoter methylation in the regulation of Pregnane X receptor in colon cancer cells.
Habano W; Gamo T; Terashima J; Sugai T; Otsuka K; Wakabayashi G; Ozawa S
BMC Cancer; 2011 Feb; 11():81. PubMed ID: 21342487
[TBL] [Abstract][Full Text] [Related]
9. Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor.
Schmiedlin-Ren P; Thummel KE; Fisher JM; Paine MF; Watkins PB
Drug Metab Dispos; 2001 Nov; 29(11):1446-53. PubMed ID: 11602520
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines.
Zhuang SH; Schwartz GG; Cameron D; Burnstein KL
Mol Cell Endocrinol; 1997 Jan; 126(1):83-90. PubMed ID: 9027366
[TBL] [Abstract][Full Text] [Related]
11. Characterization of androgen-regulated expression of CYP3A5 in human prostate.
Moilanen AM; Hakkola J; Vaarala MH; Kauppila S; Hirvikoski P; Vuoristo JT; Edwards RJ; Paavonen TK
Carcinogenesis; 2007 May; 28(5):916-21. PubMed ID: 17116727
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.
Giangreco AA; Dambal S; Wagner D; Van der Kwast T; Vieth R; Prins GS; Nonn L
J Steroid Biochem Mol Biol; 2015 Apr; 148():156-65. PubMed ID: 25305352
[TBL] [Abstract][Full Text] [Related]
13. The role of Vitamin D3 metabolism in prostate cancer.
Lou YR; Qiao S; Talonpoika R; Syvälä H; Tuohimaa P
J Steroid Biochem Mol Biol; 2004 Nov; 92(4):317-25. PubMed ID: 15663995
[TBL] [Abstract][Full Text] [Related]
14. C-jun N-terminal kinase modulates 1,25-dihydroxyvitamin D3-induced cytochrome P450 3A4 gene expression.
Yasunami Y; Hara H; Iwamura T; Kataoka T; Adachi T
Drug Metab Dispos; 2004 Jul; 32(7):685-8. PubMed ID: 15205382
[TBL] [Abstract][Full Text] [Related]
15. Correlated downregulation of VDR and CYP3A4 in colorectal cancer.
Sadeghi H; Hashemnia V; Nazemalhosseini-Mojarad E; Ghasemi MR; Mirfakhraie R
Mol Biol Rep; 2023 Feb; 50(2):1385-1391. PubMed ID: 36469261
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a stable human cell line, HPL-A3, for use in reporter gene assays of cytochrome P450 3A inducers.
Sekimoto M; Sano S; Hosaka T; Nemoto K; Degawa M
Biol Pharm Bull; 2012; 35(5):677-85. PubMed ID: 22687401
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Murthy S; Agoulnik IU; Weigel NL
Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
[TBL] [Abstract][Full Text] [Related]
19. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
[TBL] [Abstract][Full Text] [Related]
20. Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia.
Zhou C; Assem M; Tay JC; Watkins PB; Blumberg B; Schuetz EG; Thummel KE
J Clin Invest; 2006 Jun; 116(6):1703-12. PubMed ID: 16691293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
